3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Neuroendocrine Tumors
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Gemcitabine
18
pembrolizumab
16
Cisplatin
16
Nivolumab
15
atezolizumab
11
durvalumab
9
Specimen Handling
9
Magnetic Resonance Spectroscopy
9
Cystectomy
8
Carboplatin
7
Ipilimumab
6
Fluorouracil
6
avelumab
5
Mitomycin
5
sacituzumab govitecan
4
erdafitinib
4
enfortumab vedotin
4
Surgical Procedures, Operative
4
Immunoglobulin G
4
Disulfides
4
Biopsy
4
tremelimumab
3
cabozantinib
3
Transurethral Resection of Bladder
3
Surveys and Questionnaires
3
Radiation
3
Platinum
3
Paclitaxel
3
Leucovorin
3
Docetaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Urinary Bladder Neoplasms
×
Radionuclide Imaging
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled